Which Innovations Are Set to Transform the Medical Device Market?
The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics. On this episode of I Don’t Care, Host Kevin Stevenson talked with Dr. Dan…
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Promoted content from I Don't Care on MarketScale.
Free workspace
Turn your Healthcare expertise into content.
Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.
The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.
On this episode of I Don’t Care, Host Kevin Stevenson talked with Dr. Dan Burnett, President, and CEO of Theranova, an experienced medical device developer with a track record of creating innovating and practical solutions to large markets with unmet needs. The duo dug into Theranova and spinning out companies after funding.
Acting as a medical device incubator or venture studio, Theranova builds medical devices, nurtures them, raises money for them, and once they get to the right stage, they bring on a management team and forge them into their own entity.
“Theranova is, essentially, an idea generator and a company generator,” Burnett said, “that averages a little over one a year in terms of companies we form and spin out. We’ve had 17 in the last 15 years.”
They focus on various healthcare areas, and it just depends on where they see a need. However, they have been honing in on mechatronics and advanced sensing technologies and using those to gather proprietary data streams, which they believe will revolutionize medicine.
Where they once let go of companies quickly, Theranova is holding onto companies longer and longer. Previously, a company would spin out with Series A financing, become its own company and leave Theranova.
“Increasingly, Theranova is investing in these companies, and we’re getting grants and angel capital that allow it to stay inside of Theranova longer,” Burnett said. “By the time it spins out, it is of greater value than the initial spinout stage.”
Listen to hear more about where Theranova sees itself in five to ten years.
Listen to Previous Episodes of I Don’t Care!
Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale
Part of this channel
I Don't Care
Candid healthcare leadership conversations with Kevin Stevenson
Your experts belong here
Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.
Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.
